(Q68202674)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolites (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

2

G Ehninger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

U Schuler

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

T Wagner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

248-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

Bone-marrow transplantation (first of two parts).

22 September 2019

cites work

1 reference

12 December 2020

Allogeneic marrow grafting for treatment of aplastic anemia.

1 reference

12 December 2020

Decreased plasma half-life of cyclophosphamide during repeated high-dose administration

1 reference

12 December 2020

Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation

1 reference

12 December 2020

On the binding of cyclophosphamide and cyclophosphamide-metabolites to serum-albumin (author's transl)

1 reference

12 December 2020

Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)

1 reference

12 December 2020

Fluorometric determination of acrolein and related compounds with m-aminophenol

1 reference

12 December 2020

The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity

1 reference

12 December 2020

Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism

1 reference

12 December 2020

Studies of the effects of cyclophosphamide, vincristine, and prednisone on some hepatic oxidations and conjugations

1 reference

12 December 2020

Fluorometric determination of "activated" cyclophosphamide and ifosfamide in blood (author's transl)

1 reference

12 December 2020

Denaturation of cytochrome P-450 by cyclophosphamide metabolites

1 reference

12 December 2020

[Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)]

1 reference

12 December 2020

PLasma half-life and urinary excretion of cyclophosphamide in children

1 reference

12 December 2020

Clinical pharmacology of cyclophosphamide

1 reference

12 December 2020

Inhibition of NADPH-cytochrome P450 reductase by cyclophosphamide and its metabolites

1 reference

12 December 2020

Enzymatic toxicogenation of ?Activated? cyclophosphamide by 3??5? exonucleases

1 reference

12 December 2020

Identification and pharmacokinetics of cyclophosphamide (NSC-26271) metabolites in vivo

1 reference

12 December 2020

ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO

1 reference

12 December 2020

Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test

1 reference

12 December 2020

Pharmacokinetics of "activated" cyclophosphamide and therapeutic efficacies

1 reference

12 December 2020

Characterization and quantitative estimation of activated cyclophosphamide in blood and urine

1 reference

12 December 2020

Inhibition of hepatic microsomal enzymes by alkylating agents

1 reference

12 December 2020

The metabolism of cyclophosphamide. Dose dependency and the effect of long-term treatment with cyclophosphamide

1 reference

12 December 2020

Decreased half life of cyclophosphamide in patients under continual treatment

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00570495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315284%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference